NCT03378817

Brief Summary

Kidney transplantation (KT) has emerged as the mainstay of treatment for end-stage kidney disease. In an effort to address the widening gap between demand and supply of donor organs, there has been an increase in the numbers of "marginal" or functionally impaired renal allografts that had to be accepted for KT over the decades. The use of extended criteria donor (ECD) allografts is associated with a higher incidence of primary graft non-function (PNF) and/or delayed graft function (DGF). Hypothermic oxygenated machine perfusion (HOPE) has been successfully tested in pre-clinical experiments and in a few clinical series of donation after cardiac death (DCD) in liver transplantation. The present trial is an investigator-initiated pilot study on the effects of HOPE on ECD-allografts in donation after brain death (DBD) KT. Fifteen kidney allografts will be submitted to 2 hours of HOPE before implantation and are going to be compared to a case matched group transplanted after conventional cold storage (CCS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

April 7, 2020

Status Verified

April 1, 2020

Enrollment Period

1.8 years

First QC Date

December 8, 2017

Last Update Submit

April 3, 2020

Conditions

Keywords

Extended criteria donorDonation after brain deathHOPEKidney transplantation

Outcome Measures

Primary Outcomes (1)

  • DGF

    DGF (defined as the need for dialysis in the first 7-days post-transplantation)

    7 days post-transplant

Secondary Outcomes (8)

  • CRR2, CRR5

    5 days post-transplant

  • postoperative complications

    Subjects will be followed 6 months postoperatively

  • Cumulative postoperative complications

    Subjects will be followed 6 months postoperatively

  • Duration of intensive care stay

    Subjects will be followed 6 months postoperatively

  • Duration of hospital stay

    Subjects will be followed 6 months postoperatively

  • +3 more secondary outcomes

Study Arms (2)

Conventional cold storage

ACTIVE COMPARATOR

Conventional static cold storage (CCS) on temperature 0-4 °C from organ procurement (historical case matched group)

Other: Conventional cold storage

Hypothermic oxygenated perfusion (HOPE)

EXPERIMENTAL

HOPE for 1 hour via the renal artery in a recirculating and pressure controlled system, Belzer (UW) machine perfusion solution, perfusate temperature 0-4 °C, perfusate oxygenation pO2 of 60-80 kPa Other Name: Hypothermic machine perfusion (HMP)

Procedure: HOPE

Interventions

HOPEPROCEDURE

HOPE for 1 hour via the renal artery in a recirculating and pressure controlled system, Belzer (UW) machine perfusion solution, perfusate temperature 0-4 °C, perfusate oxygenation pO2 of 60-80 kPa Other Name: Hypothermic machine perfusion (HMP)

Hypothermic oxygenated perfusion (HOPE)

No intervention

Conventional cold storage

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dialysis-requiring Patients, suffering from end stage kidney disease, listed for KT and receiving ECD organs at the Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Informed consent is obtained from all subjects participating in the trial by a qualified member of the study team.
  • ECD is defined as followed: deceased donors \> 60 years and older, and those aged between 50-59 years with at least two of the following conditions: cerebrovascular cause of death, serum Creatinine greater than 1.5 mg/dL (132.6 µmol/L), history of arterial hypertension

You may not qualify if:

  • Recipients of living donor kidney transplants
  • Previous kidney transplantation
  • Participation in other kidney related trials
  • The subject is unwilling or unable to follow the procedures outlined in the protocol
  • The subject is mentally or legally incapacitated
  • Non-German or non-English speakers
  • Family members of the investigators or employees of the participating department
  • The subject is mentally or legally incapacitated
  • The subject suffers from uncontrolled bacterial or viral infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery and Transplantation, University Hospital RWTH Aachen

Aachen, 52074, Germany

Location

Related Publications (2)

  • Meister FA, Czigany Z, Rietzler K, Miller H, Reichelt S, Liu WJ, Boecker J, Moeller MJ, Tolba RH, Hamesch K, Strnad P, Boor P, Stoppe C, Neumann UP, Lurje G. Decrease of renal resistance during hypothermic oxygenated machine perfusion is associated with early allograft function in extended criteria donation kidney transplantation. Sci Rep. 2020 Oct 20;10(1):17726. doi: 10.1038/s41598-020-74839-7.

  • Meister FA, Czigany Z, Bednarsch J, Bocker J, Amygdalos I, Morales Santana DA, Rietzler K, Moeller M, Tolba R, Boor P, Rohlfs W, Neumann UP, Lurje G. Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts from Brain Dead Donors: Protocol for a Prospective Pilot Study. JMIR Res Protoc. 2019 Oct 14;8(10):e14622. doi: 10.2196/14622.

MeSH Terms

Conditions

Reperfusion Injury

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Georg Lurje, M.D.

    RWTH Aachen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot study, case matched (1:2)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Transplant Surgeon

Study Record Dates

First Submitted

December 8, 2017

First Posted

December 20, 2017

Study Start

December 5, 2017

Primary Completion

September 30, 2019

Study Completion

March 30, 2020

Last Updated

April 7, 2020

Record last verified: 2020-04

Locations